Chromocell Therapeutics Corporation (CHRO)

USD 0.59

(-4.76%)

Annual Balance Sheets

(In USD)
Breakdown 2023 2022 2021 2020
Total Assets 96.39 Thousand 55.07 Thousand - 71.87 Thousand
Total Current Assets 96.39 Thousand 55.07 Thousand - 71.87 Thousand
Cash And Short Term Investments 96.39 Thousand 55.07 Thousand - -
Cash and Cash Equivalents 96.39 Thousand 55.07 Thousand - -
Short Term Investments - - - -
Net Receivables - - - -
Inventory - - - -
Other Current Assets - - - 71.87 Thousand
Total Non-Current Assets - - - -
Net PPE - - - -
Good Will And Intangible Assets - - - -
Good Will - - - -
Intangible Assets - - - -
Long-Term Investments - - - -
Tax Assets - - - -
Other Non Current Assets - - - -
Other Assets - - - -
Total Liabilities 6.54 Million 3.76 Million 3.68 Million 3.64 Million
Total Current Liabilities 6.54 Million 3.76 Million 2.58 Million 3.64 Million
Account Payables 4.62 Million 2.99 Million 2.58 Million 3.4 Million
Tax Payables - - - -
Short Term Debt 1.26 Million 540.43 Thousand - 241.79 Thousand
Deferred Revenue - 1.00 - -3.4 Million
Other Current Liabilities 651.33 Thousand 227.26 Thousand - 3.4 Million
Total Non Current Liabilities - - 1.09 Million -
Long-Term Debt - - 1.09 Million -
Deferred Revenue Non Current - - - -
Deferred Tax Liabilities Non Current - - - -
Other Non Current Liabilities - - - -
Other Liabilities 0.00 - - -
Total Equity -6.44 Million -3.7 Million -3.68 Million -3.57 Million
Stock Holders Equity -6.44 Million -3.7 Million -3.68 Million -3.57 Million
Common Stock 391.00 10 Thousand - -
Retained Earnings -13.51 Million -6.13 Million -3.68 Million -3.57 Million
Accumulated other comprehensive income -391.00 -9999.00 - -
Common Stock Equity -6.44 Million -3.7 Million -3.68 Million -3.57 Million
Capital Lease Obligation - - - -
Total Investments - - - -
Total Debt 1.26 Million 540.43 Thousand 1.09 Million 241.79 Thousand
Net Debt 1.17 Million 485.35 Thousand 1.09 Million 241.79 Thousand

Balance Sheet Charts